Ocugen Insider Trades
NASDAQ: OCGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $25.83K
- Sales
- 2 · $589.11K
- Shares bought / sold
- 21.00K / 525.99K
- Net activity
- Net selling $563,280
Ocugen insider activity
Over the last 12 months, Ocugen insiders reported 8 transactions on SEC Form 4: 1 open-market purchase and 2 sales. Insiders bought $25,830 and sold $589,110 worth of stock, for net insider selling of $563,280. The largest seller was Musunuri Shankar, with $589,110 in reported sales.
The most recent filing shows Musunuri Shankar (Chief Executive Officer) selling 468,727 shares at $1.12 on Sep 9, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OCGN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
OCGN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 9, 2026 | Musunuri ShankarChief Executive Officer | Sale | 57,264 | $64.14K | Form 4 |
| Sep 9, 2026 | Musunuri ShankarChief Executive Officer | Sale | 468,727 | $524.97K | Form 4 |
| Jun 15, 2026 | Johnson-Greene Treerita EssalimaChief Financial Officer | Buy | 21,000 | $25.83K | Form 4 |
| Apr 1, 2026 | Zhang JungeDirector | Option exercise | 66,929 | $95.04K | Form 4 |
| Apr 1, 2026 | Zhang JungeDirector | Option exercise | 112,205 | $51.61K | Form 4 |
| Apr 1, 2026 | Zhang JungeDirector | Option exercise | 15,000 | $7.65K | Form 4 |
| Jan 2, 2026 | Ramachandran RameshChief Accounting Officer | Award | 207,300 | — | Form 4 |
| Jan 2, 2026 | Musunuri ShankarChief Executive Officer | Award | 3,123,201 | — | Form 4 |
| Jan 3, 2025 | Upadhyay ArunSee Remarks | Tax withholding | 41,633 | $37.24K | Form 4 |
| Jan 3, 2025 | Musunuri ShankarChief Executive Officer | Tax withholding | 177,146 | $158.46K | Form 4 |
| Nov 26, 2024 | Fernandes PrabhavathiDirector | Buy | 10,000 | $9.10K | Form 4 |
| Nov 22, 2024 | Castillo KirstenDirector | Buy | 25,000 | $22.85K | Form 4 |
| Sep 16, 2024 | Upadhyay ArunSee Remarks | Tax withholding | 842 | $985.14 | Form 4 |
| Jun 17, 2024 | Upadhyay ArunSee Remarks | Tax withholding | 917 | $1.30K | Form 4 |
| Jan 3, 2024 | Upadhyay ArunSee Remarks | Tax withholding | 41,633 | $27.19K | Form 4 |
| Jan 3, 2024 | Musunuri ShankarChief Executive Officer | Tax withholding | 180,204 | $117.67K | Form 4 |
| Sep 16, 2023 | Upadhyay ArunSee Remarks | Tax withholding | 842 | $345.22 | Form 4 |
| Jun 16, 2023 | Upadhyay ArunChief Scientific Officer | Tax withholding | 917 | $467.67 | Form 4 |
| Jun 14, 2023 | Zhang JungeDirector | Buy | 200,278 | $100.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4